These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 7689218

  • 1. A monoclonal antibody Fab fragment crystallized with and without a peptide epitope from HIV.
    Pfeffer-Hennig S, Wessner H, Hennig M, Dauter Z, Hausdorf G, Höhne WE.
    Proteins; 1993 Aug; 16(4):437-9. PubMed ID: 7689218
    [Abstract] [Full Text] [Related]

  • 2. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
    Stura EA, Stanfield RL, Fieser GG, Silver S, Roguska M, Hincapie LM, Simmerman HK, Profy AT, Wilson IA.
    Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
    [Abstract] [Full Text] [Related]

  • 3. Crystallization, preliminary X-ray diffraction study, and crystal packing of a complex between anti-hen lysozyme antibody F9.13.7 and guinea-fowl lysozyme.
    Lescar J, Riottot MM, Souchon H, Chitarra V, Bentley GA, Navaza J, Alzari PM, Poljak RJ.
    Proteins; 1993 Feb; 15(2):209-12. PubMed ID: 7680133
    [Abstract] [Full Text] [Related]

  • 4. Crystallization of the Fab from a human monoclonal antibody against gp 41 of human immunodeficiency virus type I.
    Casale E, Wenisch E, He XM, Righetti PG, Snyder RS, Jungbauer A, Tauer C, Ruker F, Carter DC.
    J Mol Biol; 1990 Dec 05; 216(3):511-2. PubMed ID: 2258926
    [Abstract] [Full Text] [Related]

  • 5. Preliminary crystallographic analysis of the Fab fragment of an antibody against HIV gp120.
    Vyas MN, Vyas NK, Liou RS, Chang TW, Quiocho FA.
    J Mol Biol; 1990 Jul 05; 214(1):23-4. PubMed ID: 1695249
    [Abstract] [Full Text] [Related]

  • 6. Crystallization and preliminary X-ray data for the human transthyretin-retinol-binding protein (RBP) complex bound to an anti-RBP Fab.
    Malpeli G, Zanotti G, Gliubich F, Rizzotto A, Nishida SK, Folli C, Berni R.
    Acta Crystallogr D Biol Crystallogr; 1999 Jan 05; 55(Pt 1):276-8. PubMed ID: 10089423
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.
    J Mol Biol; 2008 Oct 17; 382(4):910-9. PubMed ID: 18692506
    [Abstract] [Full Text] [Related]

  • 8. Interaction of epitope-related and -unrelated peptides with anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab fragment.
    Welfle K, Misselwitz R, Höhne W, Welfle H.
    J Mol Recognit; 2003 Oct 17; 16(1):54-62. PubMed ID: 12557239
    [Abstract] [Full Text] [Related]

  • 9. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
    Lescar J, Stouracova R, Riottot MM, Chitarra V, Brynda J, Fabry M, Horejsi M, Sedlacek J, Bentley GA.
    Protein Sci; 1996 May 17; 5(5):966-8. PubMed ID: 8732768
    [Abstract] [Full Text] [Related]

  • 10. Crystallization and preliminary X-ray analysis of an anti-staphylococcal nuclease-staphylococcal nuclease complex and of a second anti-staphylococcal nuclease antibody.
    Chang CY, Whitaker PB, Tabernero L, Einspahr H, Workman L, Benjamin DC, Sheriff S.
    J Mol Biol; 1994 May 27; 239(1):154-7. PubMed ID: 8196044
    [Abstract] [Full Text] [Related]

  • 11. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment.
    Li H, Lawson CL.
    J Struct Biol; 1995 May 27; 115(3):335-7. PubMed ID: 8573475
    [Abstract] [Full Text] [Related]

  • 12. Preliminary crystallographic analysis of a Fab specific for P-glycoprotein with and without bound peptide.
    Vasudevan S, Johns KL, Rose DR.
    J Mol Biol; 1994 Sep 02; 241(5):736-8. PubMed ID: 7915332
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preparation, crystallization and preliminary X-ray analysis of a complex between the Plasmodium vivax sexual stage 25 kDa protein Pvs25 and a malaria transmission-blocking antibody Fab fragment.
    Saxena AK, Singh K, Long CA, Garboczi DN.
    Acta Crystallogr D Biol Crystallogr; 2004 Nov 02; 60(Pt 11):2054-7. PubMed ID: 15502325
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
    Hochleitner EO, Borchers C, Parker C, Bienstock RJ, Tomer KB.
    Protein Sci; 2000 Mar 02; 9(3):487-96. PubMed ID: 10752610
    [Abstract] [Full Text] [Related]

  • 18. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
    Verdaguer N, Mateu MG, Bravo J, Tormo J, Giralt E, Andreu D, Domingo E, Fita I.
    Proteins; 1994 Feb 02; 18(2):201-3. PubMed ID: 8159669
    [Abstract] [Full Text] [Related]

  • 19. Purification, crystallization, X-ray diffraction analysis and phasing of a Fab fragment of monoclonal neuroantibody alphaD11 against nerve growth factor.
    Covaceuszach S, Cassetta A, Cattaneo A, Lamba D.
    Acta Crystallogr D Biol Crystallogr; 2004 Jul 02; 60(Pt 7):1323-7. PubMed ID: 15213405
    [Abstract] [Full Text] [Related]

  • 20. Purification, crystallization and X-ray diffraction analysis of a recombinant Fab that recognizes a human blood-group antigen.
    Song SC, Xie K, Czerwinski M, Spitalnik SL, Wedekind JE.
    Acta Crystallogr D Biol Crystallogr; 2004 Apr 02; 60(Pt 4):788-91. PubMed ID: 15039587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.